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Swiss doctors' attitudes towards end-of-life decisions and their
determinants: a comparison of three language regions
Abstract
OBJECTIVES: To investigate attitudes to end-of-life decisions, and the influence of cultural factors and
of doctors' personal characteristics on these attitudes. 
METHOD: As part of a European research project (EURELD), a study on attitudes towards medical
end-of-life decisions was conducted among doctors in the German-, French- and Italian-speaking areas
of Switzerland. A written questionnaire was sent to a random sample of nine different types of
specialist; it presented 14 statements on end-of-life decisions and doctors were asked whether they
agreed or disagreed with them. 
RESULTS: The response rate was 64%. 1360 questionnaires were studied. The results show general
agreement with statements on the alleviation of pain and other symptoms with possible life-shortening
effect, as well as on non-treatment decisions. The language region was a strong determinant of
agreement on some attitudes towards end-of-life decisions. Agreement on the use of lethal drugs and
alleviation of pain and other symptoms with possible life-shortening effect was higher among
French-speaking than among German- and Italian-speaking doctors. For nontreatment decisions,
agreement was higher in the German-speaking region than in the French- and Italian-speaking regions of
the country. Italian-speaking doctors were strongly opposed to any kind of end-of-life decision.
Religious believers and those who attended a larger number of terminal patients tended to disagree more
often with end-of-life decisions than the other doctors. 
CONCLUSIONS: In end-of-life decision-making, Switzerland represents "Europe in miniature". The
impact on end-of-life decisions of cultural factors and the number of terminal patients attended needs
further consideration.
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Objectives: To investigate attitudes to end-of-
life decisions, and the influence of cultural factors
and of doctors’ personal characteristics on these
attitudes.
Method: As part of a European research proj-
ect (EURELD), a study on attitudes towards med-
ical end-of-life decisions was conducted among
doctors in the German-, French- and Italian-
speaking areas of Switzerland. A written question-
naire was sent to a random sample of nine differ-
ent types of specialist; it presented 14 statements
on end-of-life decisions and doctors were asked
whether they agreed or disagreed with them.
Results: The response rate was 64%. 1360
questionnaires were studied. The results show
general agreement with statements on the allevia-
tion of pain and other symptoms with possible life-
shortening effect, as well as on non-treatment de-
cisions. The language region was a strong deter-
minant of agreement on some attitudes towards
end-of-life decisions. Agreement on the use of
lethal drugs and alleviation of pain and other
symptoms with possible life-shortening effect 
was higher among French-speaking than among
German- and Italian-speaking doctors. For non-
treatment decisions, agreement was higher in the
German-speaking region than in the French- and
Italian-speaking regions of the country. Italian-
speaking doctors were strongly opposed to any
kind of end-of-life decision. Religious believers
and those who attended a larger number of termi-
nal patients tended to disagree more often with
end-of-life decisions than the other doctors.
Conclusions: In end-of-life decision-making,
Switzerland represents “Europe in miniature”.
The impact on end-of-life decisions of cultural fac-
tors and the number of terminal patients attended
needs further consideration. 
Key words: end-of-life decisions; doctors; determi-
nants; Switzerland
Until the European research project “Medical
end-of-life decisions” (EURELD/European end-
of-life decisions) was undertaken, there were no
quantifiable results on end-of-life decisions made
by Swiss doctors for their patients. This project in-
vestigated the practices, attitudes and intentions of
doctors regarding end-of-life decisions (decisions
about non-treatment, euthanasia, assisted suicide,
alleviation of pain or other symptoms with pos-
sible life-shortening effect) in six European coun-
tries. The first empirical results of this quantitative
study showed that medical end-of-life decisions
frequently preceded dying in the German-speak-
ing part of Switzerland: in the year 2001, every sec-
ond death was preceded by an end-of-life decision,
with non-treatment decisions being the most com-
mon [1]. The second part of this European project
in Switzerland included the French-speaking and
Italian-speaking regions.
It has been found that end-of-life decisions are
determined by the particular clinical situation, as
well as by certain personal characteristics of the
doctors concerned and cultural differences be-
tween countries. Terminal illness, advanced age,
no hope of recovery, unbearable pain and suffer-
ing, a patient’s request not to prolong his/her life
or to hasten his/her death have been found to be
relevant clinical factors in the different studies car-
ried out [2, 3]. Among the doctors’ personal char-
acteristics, gender, age, religion and speciality are
the potential determinants most often investi-
gated. Religious affiliation and commitment have
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been consistently indicated as strong determinants
of attitude towards medical end-of-life decisions
[2–6]. Gender differences have not been found in
most studies [7]. Some types of specialist are less
likely to support end-of-life decisions than others:
oncologists are less supportive of euthanasia or as-
sisted suicide than other specialists [3, 8, 9]. Cul-
tural factors and other country-specific factors
have also been found to be relevant to the differ-
ences between countries in practices and attitudes
to end-of-life decisions [1, 5, 6, 9].
Apart from these factors, end-of-life decision-
making practices, as well as attitudes and intended
behaviour, may be associated with the legal back-
ground. In Switzerland, non-treatment decisions
and the alleviation of pain or other symptoms with
possible life-shortening effect are legal but are not
regulated in the Swiss Penal Code. Assisted suicide
is allowed if it is performed disinterestedly (Art.
115) whilst euthanasia is prohibited in all circum-
stances (Art. 111, 113 and 114).
The present article describes the Swiss results
of the second study conducted within the Euro-
pean project “Medical end-of-life decisions” [9],
which focused on attitudes and intended behaviour
and their determinants. As this study was con-
ducted in the German-, French- and Italian-speak-
ing parts of Switzerland, we had the opportunity
to investigate the influences of cultural factors 
as well as doctors’ personal characteristics. The
objectives were as follows: firstly, to describe the
attitudes towards end-of-life decisions in the
German-, French- and Italian-speaking parts of
Switzerland, and secondly, to discover the extent
to which these attitudes are determined by cultural
factors (language regions) and by doctors’ personal
characteristics. 
Methods
Design: Within the EURELD-project, an eight-page
questionnaire with pre-structured questions was sent to
practitioners of nine different specialties in Switzerland
(German-, French- and Italian-speaking regions) between
October and November 2002.
Population: Doctors from the following specialties
were asked to participate: anaesthesiology, general prac-
tice, geriatrics, gynaecology, internal medicine, neurol-
ogy, oncology, pulmonology and surgery. A random sam-
ple of 300 doctors for each speciality was drawn from the
professional registers of the Swiss Medical Association
(FMH). When there were fewer than 300 doctors work-
ing in a speciality, all specialists were included in the sam-
ple. The response rate for doctors who could be tracked
was 64% (n = 1449). Of these, 3.6% (n = 52) indicated that
they were not currently working and 2.6% (n = 37) did not
answer this question, so both groups were excluded from
the analysis. 1360 questionnaires were analysed. The 
data-collection procedure precluded identification of any
of the doctors.
Measurement tool: The questionnaire consisted of 
pre-structured questions. A common English version was
translated into the languages of the different regions and
then translated back into English to check for inconsisten-
cies. Besides questions on doctors’ personal characteris-
tics, questions were asked about intended behaviour, 
attitudes and experience concerning end-of-life care. 
Attitudes were assessed by studying the responses to a list
of 14 statements. Statements 1, 5, 9 and 10 were derived
from the scientific literature [10–13]. The remaining
statements were formulated by the research group. State-
ment 8, which concerned the medical role in cases of 
assisted suicide, was omitted in the Italian version of the
questionnaire.
The doctors’ personal characteristics considered in
this paper are “gender”, “age”, “speciality”, “number of
terminal patients attended during the last 12 months” and
“life stance”. “Life stance” describes importance of reli-
gion/philosophy of life in end-of-life decision-making 
(religion important/very important, philosophy of life 
important/very important, no religion/philosophy of life
or religion/philosophy of life not important). “Life stance”
is a derived variable from the variables “religion/philo-
sophy of life”1 and “importance of religion/philosophy of
life in professional attitudes towards end-of-life decision-
making”2. 
Definitions: When referring to medical decisions, a
precise description was given rather than using terms that
would be open to interpretation. Questions were asked
about: 
– Withholding or withdrawing treatment, taking into
account the probability or certainty that this would
hasten the end of the patient’s life.
– Greater alleviation of pain and/or symptoms by using
drugs such as opioids, taking into account the probabil-
ity or certainty that this would hasten the end of the 
patient’s life.
– Administering drugs with the explicit intention of
hastening the end of the patient’s life (with or without
the patient’s explicit request).
– Prescribing or supplying drugs at the express wish of a
patient, with the explicit intention of hastening the end
of life.
Statistical analysis: Results were corrected for stratifi-
cation to make them representative for all doctors in the
specialties sampled. Each case was weighted according to
the population size of the speciality concerned divided by
the number of questionnaires returned for this speciality.
Weighted percentage of agreement (strongly
agree/agree) with statements and 95% confidence inter-
vals were reported. Separate multivariate logistic regres-
sion was performed for each statement (strongly
agree/agree) to determine the association with the lan-
guage regions and doctors’ personal characteristics. Inde-
pendent variables were: “language region” (German-,
French- and Italian-speaking), “sex” (male, female), “age”
1 The wording of the question was: “What do you consider
to be your religion or philosophy of life?” Answers were
classified for analysis into three categories: “any reli-
gion”, “any specific philosophy of life” and “no specific
philosophy of life/no religion”, including cases e.g. secu-
larist, non-believer.
2 The wording of the question was: “How important is your
religion or philosophy of life in your professional attitude
towards end-of-life decision-making?” Answers were clas-
sified for analysis into two categories: “very important/
important” and “less important/not important”.
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(≤50 years, >50 years), “number of terminal patients at-
tended during the last 12 months” (≤4 terminal patients,
>4 terminal patients), and “life stance” (religion impor-
tant/very important, philosophy of life important/very
important, no religion/philosophy of life or religion/
philosophy of life not important). Each of the categories
of the variables “language regions” and “life stance” was
dummy coded and entered as distinct variables. 
“Survey” STATA 8 commands were used to take
strata and weighting [14] into consideration. In logistic re-
gression analysis, independent variables are not allowed to
correlate closely with one another. Since there was a close
correlation between speciality and number of terminally
ill patients treated, the variable ‘speciality’ had to be ex-
cluded from the analysis. 
Results
Responses and personal characteristics 
of doctors (table 1)
1360 questionnaires were studied. No statisti-
cally significant differences in response rates were
found between the language regions (German-
speaking and French-speaking regions: 64%; Ital-
ian-speaking region: 63%) but there were statisti-
cally significant differences between the speciali-
ties (54% in gynaecology and 74% in geriatrics).
Most of the doctors were males aged over 40. Ap-
prox. 37% were general practitioners. Some 20%
of them had not attended a terminal patient dur-
ing the last 12 months (varying between 17% in
the German region and 25% in the Italian region).
The geriatricians and oncologists had treated the
largest number of terminally ill patients (data not
shown in table): 87% of these two groups had man-
aged more than 10 terminally ill patients during
the last 12 months. They were followed by the
pulmonologists, anaesthesiologists and internists
(some 40% of these had treated more than 10 ter-
minally ill patients), surgeons (30%) and general
practitioners (24%). Neurologists and gynaecolo-
gists were less often involved in end-of-life deci-
sions (only 10% and 2% respectively had managed
more than 10 terminally ill patients). For 47% of
the doctors religion and for 8% philosophy of life
was important in professional attitudes towards
decision-making.
Agreement with statements on end-of-life
decisions (table 2)
Table 2 shows the percentages of doctors who
“strongly agreed” or “agreed” with statements on
end-of-life decisions. The highest rate of agree-
ment occurred for the statements relating to the
alleviation of pain and other symptoms with pos-
sible life-shortening effect (Statement 4: varying
Swiss German Swiss French Swiss Italian All three regions
Number of questionnaires studied 945 363 52 1360
Gender Male 79 81 97 80
Female 21 19 3 20
Age <40 15 12 6 14
40–50 41 42 29 41
>50 44 46 65 45
Speciality General practice 40 28 29 37
Anaesthesiology 10 12 6 10
Geriatrics 1 1 2 1
Gynaecology 12 14 12 12
Internal medicine 19 26 22 21
Neurology 3 4 6 3
Oncology 2 2 6 2
Pulmonology 2 4 1 3
Surgery 12 8 17 11
Number of terminal patients attended during the last 12 months
0 17 26 25 20
1–4 31 35 24 32
5–9 20 17 25 20
≥10 31 22 26 29
Life stance towards end-of-life decision-making
Religion (very) important 49 38 49 47
Philosophy of life (very) important 8 7 13 8
No religion/philosophy of life or religion/ 42 54 38 45
philosophy of life not important
Table 1
Questionnaires stud-
ied (number) and
personal characteris-
tics of the doctors
(weighted percent-
ages).
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between 95% and 99%; Statement 3: varying be-
tween 77% and 94%), as well as for the non-treat-
ment decision at a patient’s request (Statement 1:
varying between 90% and 95%). The lowest rate
of agreement was found in relation to the ‘life
preservation’ statement corresponding to the Hip-
pocratic oath (Statement 9: 7% for the whole of
Switzerland, varying between 4% and 33% over
the three language regions). Agreement with the
use of lethal drugs varied between 29% and 65%
(Statements 11 and 12); this agreement is signifi-
cantly higher if there is an explicit request by a ter-
minal patient with extreme uncontrollable pain
and distress (Statement 11), than if the patient is
not competent to make such a request (Statement
12). 
The biggest differences between the language
regions were found for the “use of lethal drugs at
explicit request” (Statement 11) and “life preserva-
tion” (Statement 9). The agreement with State-
ment 11 is statistically significantly lower in the
Italian-speaking part than in the French-speaking
region and the agreement with “life preservation”
is significantly higher in the Italian-speaking area
than in French- and German-speaking Switzer-
land.
Determinants of agreement (Table 3)
Language region: The language region was a
strong determinant of agreement with statements
concerning alleviation of pain and other symptoms
(Statements 3 and 4) as well as for the non-treat-
ment decisions (Statement 1), the use of lethal
drugs (Statements 11 and 12) and life preservation
(Statement 9). Doctors from the French-speaking
region were less in favour of non-treatment de-
cisions, but more in favour of alleviation of pain
and other symptoms with possible life-shortening 
side effects, and the use of lethal drugs, than doc-
tors from German-speaking Switzerland. Doctors
from the Italian-speaking region supported alle-
viation of pain and symptoms less often, and 
supported life preservation more often than their
German-speaking counterparts. The strongest 
influence of the language region was found in 
attitudes towards life preservation and alleviation
of pain and other symptoms. The odds ratio for
doctors from the Italian-speaking area assenting to
“life preservation” is ten times higher than for doc-
tors from the German-speaking region, while the
odds ratio of doctors from the French-speaking
part, with support for terminally ill patients receiv-
ing drugs to relieve pain and suffering, even if these
Swiss Swiss Swiss All three 
German French Italian regions
Number of questionnaires studied 945 363 52 1360
1. Doctors should comply with a patient’s request to withhold or 95 91 90 94
withdraw life-sustaining treatment (93–96) (86–94) (72–97) (92–95)
2. If a patient is not competent, relatives should be allowed to decide 53 46 47 51
whether or not to withhold or withdraw life-sustaining treatment (49–57) (39–52) (31–64) (48–55)
3. Decisions to intensify the alleviation of pain and/or symptoms by using 94 93 77 93
potentially life-shortening drugs should be discussed with the patient (92–95) (88–96) (58–89) (91–94)
4. If necessary, a terminally ill patient should receive drugs to relieve pain 95 99 96 96
and suffering, even if these drugs may hasten the end of the patient’s life (93–96) (98–100) (84–99) (94–97)
5. A person should have the right to decide whether or not to hasten 60 67 50 61
the end of his or her life (56–63) (61–73) (33–67) (58–64)
6. Sufficient availability of high-quality palliative care averts almost  70 64 77 69
all requests for euthanasia or assisted suicide (67–74) (58–70) (60–89) (66–72)
7. Every person should be allowed to appoint another person to be 54 63 42 56
legally entitled to make end-of-life decisions on his or her behalf in (50–58) (56–69) (26–59) (53–59)
the event of incompetence
8. In Switzerland assisted suicide is legal if is performed disinterestedly. 46 40 – 43
It should be provided only by doctorsa (42–50) (34–46) – (40–47)
9. In all circumstances doctors should aim at preserving the lives of their 4 11 33 7
patients, even if patients ask for the hastening of the end of their lives (3–6) (8–15) (18–51) (6–9)
10. Permitting the use of drugs in lethal doses on the explicit request 30 24 41 29
of the patient will gradually lead to an increase in the use of drugs in (27–34) (19–30) (25–59) (26–32)
lethal doses unrequested by the patient 
11. The use of drugs in lethal doses at the patient’s explicit request is 53 65 41 56
acceptable for patients in terminal illness with extreme uncontrollable (49–57) (59–71) (26–58) (52–59)
pain or other distress
12. If a terminally ill patient is suffering unbearably and is not capable 29 41 42 32
of making decisions, the doctor should be allowed to administer drugs (25–33) (35-48) (26–60) (29–35)
in lethal doses
13. Permitting the use of drugs in lethal doses at the patient’s explicit 28 22 25 26
request will harm the patient-doctor relationship (25–32) (17–28) (13–43) (24–30)
14. Clear wishes on withholding or withdrawing life-sustaining treatment 87 84 75 86
of an incompetent patient as expressed in an advance directive must (84–89) (78–88) (57–88) (83–88)
always be respected, even if this could hasten the end of the patient’s life
a This item was not included in the Italian version of the questionnaire
Table 2
Weighted percentage
(95% CI) of doctors
who agreed or
strongly agreed with
each statement on
end-of-life decisions.
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drugs may hasten the end of the patient’s life, is
eight times higher than that of their German-
speaking colleagues.
Gender: Women doctors were more likely to
support the statement that adequate availability of
high quality palliative care averts almost all re-
quests for physician-assisted dying (Statement 6).
Gender was not a relevant determinant for the
other statements.
Age: Doctors aged over 50 supported the state-
ment that assistance in committing suicide should
be provided by doctors only (Statement 8) and the
“slippery slope” argument (Statement 10) more
often than younger doctors .
Number of terminal patients: Doctors who had
attended more than five terminal patients during
the last 12 months were less supportive of the right
to decide on hastening one’s own death than doc-
tors who had attended fewer terminally ill patients.
More of them supported the “slippery slope”
French- Italian- Femaleb >50 years >4 terminal Religion Philosophy 
speaking speaking oldc patients (very)  of life (very) 
regiona regiona in 12 monthsd importante importante
1. Doctors should comply with a patient’s request 0.50 0.49 0.89 1.22 0.89 0.98 4.54
to withhold or withdraw life-sustaining treatment (0.27–0.91) (0.10–2.30) (0.43–1.83) (0.72–2.07) (0.53–1.58) (0.56–1.70) (0.61–33.97)
2. If a patient is not competent, relatives should 0.72 0.73 1.19 1.13 0.94 1.04 1.43
be allowed to decide whether or not to withhold (0.51–1.01) (0.35–1.53) (0.82–1.73) (0.84–1.53) (0.70–1.26) (0.77–1.40) (0.82–2.48)
or withdraw life-sustaining treatment
3. Decisions to intensify the alleviation of pain 0.80 0.21 1.27 1.07 1.15 1.01 0.82
and/or symptoms by using potentially life- (0.39–1.61) (0.08–0.55) (0.54–2.97) (0.58–1.98) (0.64–2.09) (0.56–1.84) (0.29–2.31)
shortening drugs should be discussed with 
the patient
4. If necessary, a terminally ill patient should 7.61 1.07 0.88 1.11 1.77 0.88 3.75
receive drugs to relieve pain and suffering, (2.05–28.22) (0.24–4.80) (0.40–1.95) (0.53–2.34) (0.82–3.81) (0.43–1.79) (0.71–19.70)
even if these drugs may hasten the end of the
patient’s life
5. A person should have the right to decide 1.21 0.63 1.10 1.17 0.70 0.57 1.10
whether or not to hasten the end of his (0.86–1.70) (0.29–1.39) (0.74–1.65) (0.86–1.61) (0.52–0.95) (0.41–0.77) (0.62–1.96)
or her life
6. Adequate  availability of high-quality palliative 0.87 1.46 1.51 1.24 2.01 1.84 1.89
care averts almost all requests for euthanasia (0.62–1.23) (0.58–3.71) (1.02–2.24) (0.89–1.72) (1.47–2.76) (1.33–2.55) (1.05–3.41)
or assisted suicide
7. Every person should be allowed to empower 1.32 0.60 1.22 1.11 1.09 0.74 1.75
another person legally to make end-of-life (0.94–1.84) (0.27–1.29) (0.84–1.77) (0.82–1.51) (0.81–1.46) (0.55–0.99) (0.98–3.12)
decisions on his or her behalf in the event 
of incompetence
8. In Switzerland assisted suicide is legal if is 0.80 – 0.72 1.55 1.02 0.85 1.15
performed disinterestedly. It should be (0.57–1.12) – (0.49–1.07) (1.14–2.10) (0.75–1.37) (0.63–1.15) (0.64–2.06)
provided only by doctorsa
9. In all circumstances doctors should aim at 2.91 10.60 0.71 0.96 1.18 1.73 0.98
preserving the lives of their patients, even if (1.66–5.12) (4.19-26.80) (0.36–1.40) (0.56–1.64) (0.69–2.00) (1.01–2.97) (0.27–3.60)
patients request hastening of the end of their 
lives
10. Permitting the use of drugs in lethal doses at the 0.77 1.59 0.93 1.58 1.63 2.04 0.60
patient’s explicit request will gradually lead to (0.52–1.13) (0.67–3.81) (0.61–1.41) (1.13–2.21) (1.17–2.26) (1.46–2.85) (0.29–1.22)
an increase in the use of drugs in lethal doses 
unrequested by the patient
11. The use of drugs in lethal doses at the patient’s 1.51 0.50 1.15 1.25 0.94 0.41 1.27
explicit request is acceptable for patients with (1.07–2.15) (0.24–1.05) (0.79–1.69) (0.92–1.71) (0.70–1.28) (0.30–0.56) (0.72–2.25)
a terminal illness with extreme uncontrollable 
pain or other distress
12. If a terminally ill patient is suffering unbearably 1.65 1.71 0.81 1.18 0.82 0.62 1.27
and is not capable of making decisions, the doctor (1.16–2.35) (0.83–3.54) (0.55–1.21) (0.85–1.64) (0.59–1.13) (0.44–0.86) (0.72–2.22)
should be allowed to administer drugs in
lethal doses
13. Permitting the use of drugs in lethal doses at the 0.76 0.95 1.47 1.09 1.69 2.44 1.02
patient’s explicit request will harm the patient- (0.51–1.14) (0.40–2.26) (0.97–2.21) (0.78–1.54) (1.21–2.37) (1.73–3.45) (0.52–2.00)
doctor relationship 
14. Clear wishes on withholding or withdrawing life- 0.70 0.38 0.82 1.48 1.11 1.07 2.27
sustaining treatment of an incompetent patient (0.45–1.10) (0.15–1.01) (0.50–1.34) (0.98–2.24) (0.72–1.69) (0.72–1.60) (0.79–6.58)
as expressed in an advance directive must always 
be respected, even if this could hasten the end of  
the patient’s life
a Reference group = German-speaking region; b Reference group = ≤50 years; c Reference group = male; 
d Reference group = ≤4 terminal patients during the last 12 months; e Reference group = religion or philosophy of life not important
Table 3
Odds ratios (95% CI) for agreement with statements on end-of-life decisions (multivariate logistic regressions, significant odds ratios given in bold).
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argument, the assertion that good palliative care
averts almost all requests for physician-assisted
dying, and that allowing euthanasia will harm the
doctor-patient relationship. 
Doctors’ life stance: Religiously committed doc-
tors expressed more support for life preservation,
for the “slippery slope” argument, for the state-
ments that sufficient palliative care precludes al-
most all requests for physician-assisted dying and
that allowing euthanasia will harm the doctor-pa-
tient relationship. They agreed less often than the
other doctors to euthanasia and the ending of life
not requested by the patient, for the right to de-
cide on the hastening of one’s own death and for
appointment of another person in the case of in-
competence. Philosophically committed doctors
expressed more support for the statement that
good palliative care averts almost all requests for
euthanasia and assisted suicide. 
Discussion
The EURELD study is the first to investigate
end-of-life decisions in Switzerland and allows com-
parison between the different language regions.
The findings that a large majority of doctors in
all three language regions support non-treatment
decisions and alleviation of pain and other symp-
toms, taking into account the probability that this
would hasten the patient’s death, indicate that Swiss
doctors accept these kinds of end-of-life decision and
thus the legislation and the Swiss Academy of Med-
ical Sciences guidelines on non-treatment decisions
and alleviation of pain and other symptoms are in-
deed reflected in doctors’ attitudes.
The finding that about half of doctors accepted
the use of drugs in lethal doses at the explicit request
of terminally ill patients suffering extreme uncon-
trollable pain or other distress is difficult to discuss,
since the legal definition of  “the use” comprises both
prescription and administration. Whilst the pre-
scription of lethal drugs in Switzerland is allowed if
it is disinterested (assisted suicide), direct adminis-
tration by a doctor exposes him/her to prosecution
in all circumstances (euthanasia). However, our re-
sults, showing that approx. one third of doctors find
the use of lethal drugs acceptable if a terminally ill
patient is suffering unbearably and is not capable of
making decisions, is clearly in contravention of Swiss
law. Hence there is a divergence between the current
legislation and a minority of doctors’ attitudes.
Individual doctors’ personal characteristics as
well as cultural factors were found to affect deci-
sions, as has been shown in previous studies. The
influence of gender on end-of-life decisions was
almost negligible. Religious life stance was associ-
ated with greater agreement with life preservation,
and with the negative aspects and fears of allowing
euthanasia (e.g. the “slippery slope” argument and
harming the doctor-patient relationship); reli-
giously committed doctors were more opposed
than other doctors to euthanasia, ending of life not
requested by the patient, the right to decide on the
hastening of one’s own death and the right to em-
power another person legally to make end-of-life
decisions in case of incompetence. These findings
can be explained by traditional religious beliefs,
which tend to focus on three ideas: “(1) resistance
to ‘playing God’, (2) the commandment not to kill,
and (3) the potential spiritual benefits of suffering”
[15]. Furthermore, our results indicate that doc-
tors who treat a larger number of terminally ill
patients tend to see the negative aspects of end-
of-life decisions more often than doctors who
attend fewer such patients. These results are con-
sistent with those reported in the literature [16].
Some statistically significant differences in at-
titudes were found between the language regions.
French-speaking doctors ranked higher than their
German-speaking colleagues in supporting the use
of lethal drugs (euthanasia, assisted-suicide) and in
the alleviation of pain and other symptoms with
possible life-shortening effect, while they were less
supportive than German-speaking doctors of the
statement that doctors should comply with a pa-
tient’s request for non-treatment decisions. Doc-
tors from the Italian-speaking part were signifi-
cantly more opposed than their German-speaking
colleagues to the statement that decisions to inten-
sify the alleviation of pain and/or symptoms by
using potentially life-shortening drugs should be
discussed with the patient. Italian-speaking and
French-speaking doctors were also more support-
ive of life preservation even if the patient requests
hastening of the end of life. Due to the differences
between the language regions, the results of the
first study on practices in end-of-life decisions –
conducted in the German-speaking part of
Switzerland [1] – cannot be automatically extrap-
olated to the whole of Switzerland. The differ-
ences between the language regions cannot be ex-
plained by different regulations or guidelines con-
cerning end-of-life decisions: the same legislation
applies, and the guidelines for end-of-life decisions
from the Swiss Academy of Medical Sciences are
valid throughout Switzerland. 
When the differences in attitudes towards
end-of-life decisions between the language regions
are compared with international data, it can be
seen that the differences and patterns found in the
three Swiss language regions are similar to those
of Germany, France and Italy [5, 9]. In the 
EURONIC study, the frequency of non-treatment
decisions was highest in Germany, followed by
France. The lowest frequency was found in Italy.
The proportions of doctors who had administered
drugs for the purpose of ending life, as well as of
doctors who had administered sedatives/analgesics
to suppress pain even at risk of respiratory depres-
sion and death, were highest in France, followed
by Germany, and were lowest in Italy [5]. Thus 
it is fair to say that, with respect to attitudes to-
wards end-of-life decisions, Switzerland repre-
sents ‘Europe in miniature’.
We made an effort to reduce bias in our results
by ensuring anonymity and asking doctors what
they actually did instead of using terms that are
normally or ethically biased. However, we know
that agreement rates tend to be higher among
responders than among non-responders for eu-
thanasia, non-treatment decisions and life-pre-
serving statements (euthanasia, item 11: agree-
ment rate adjusted for non-response: 51%, unad-
justed: 56%; non-treatment, item 1: agreement
rate adjusted for non-response: 93%, unadjusted:
94%; life-preserving statements, item 9: agree-
ment rate adjusted for non-response: 6%, un-
adjusted: 7%) [17]. Thus, non-participation has
caused overestimation of the number of propo-
nents of life-shortening as well as of life-preserv-
ing end-of-life decisions. In addition, we cannot
exclude bias in our results, e.g. on grounds of so-
cial desirability. Even if the social desirability bias
is less in anonymous surveys than in interviews, it
is still possible that doctors gave socially desired
answers. If such a bias does exist, it can be assumed
that the answers are influenced by legal require-
ments as much as by other norms that may differ
with language region, speciality etc.
Apart from research on social desirability in
end-of-life surveys, further research is needed to
discover the specific cultural and social factors that
may be relevant to the differences between the lan-
guage regions, and those experiences with dying
patients which cause doctors who have treated a
large number of terminal patients to be less sup-
portive of end-of-life decisions than those with
fewer terminal patients. Also, longitudinal studies
are needed to show whether the correlations found
between age and intentions are cohort effects, and
if so, to what extent. As ‘end-of-life decisions’ are
a sensitive subject and also because some types of
end-of-life decision involve liability to prosecu-
tion, it is very important to ensure anonymity for
studies in this field.
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